OBJECTIVEYou will take home:
The major objective of this course is to review for the practicing Nephrologist the pathophysiologic and clinical advances in the major areas of Nephrology, including glomerular disease, fluid and electrolyte disorders, hypertension, dialysis, and renal transplantation. To achieve this goal, our national faculty consists of outstanding clinicians and teachers who have directly contributed to these advances. The material will be presented in several formats including lectures, case-based workshops and interactive sessions in which Nephrology and recertification board type questions will be used to highlight important clinical issues of diagnosis and therapy. Most days there will also be several "Meet the Professor" sessions at lunchtime, which will allow attendees to meet in smaller groups with members of the faculty. This program is endorsed in part by the International Society of Nephrology
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUNDAY, MARCH 20 | |
|---|---|
| 7:00 – 7:50 | Registration and Continental Breakfast |
| 7:50 – 8:00 | Introduction Burton D. Rose, MD |
| 8:00 – 9:00 | Endocrine Hypertension: Pheochromocytoma and Primary Aldosteronism William F. Young, Jr., MD, MSc |
| 9:00 – 10:00 | Resistant Hypertension David A. Calhoun, MD |
| 10:00 – 10:30 | Refreshment Break |
| 10:30 – 11:30 | Adrenal Incidentalomas William F. Young, Jr., MD, MSc |
| 11:30 – 12:30 | Diuretic Resistance: Causes and Therapeutic Response D. Craig Brater, MD |
| 12:30 – 1:45 | Lunch Break |
| 12:45 – 1:45 | Meet the Professor William F. Young, Jr., MD, MSc, David A. Calhoun, MD, D. Craig Brater, MD, Marc A. Pohl, MD |
| 1:45 – 2:45 | Dilemmas in the Treatment of Mild Hypertension Burton D. Rose, MD |
| 2:45 – 4:00 | Ischemic Renal Disease and Renovascular Hypertension Marc A. Pohl, MD |
| 4:00 – 4:30 | Refreshment Break |
| 4:30 – 5:30 | Management of Polycystic Kidney Disease Theodore I. Steinman, MD |
| 5:30 – 6:30 | Relation Between Salt and Water Burton D. Rose, MD |
| MONDAY, MARCH 21 | |
| 7:00 – 7:30 | Continental Breakfast |
| 7:30 – 8:45 | Nephrogenic Systemic Fibrosis and Contrast Nephropathy Michael R. Rudnick, MD |
| 8:45 – 9:30 | Workshop: Acid Base Burton D. Rose, MD |
| 9:30 – 10:00 | Refreshment Break |
| 10:00 – 11:00 | Renal Support in Acute Renal Failure Paul M. Palevsky, MD |
| 11:00 – 12:15 | Workshop: Fluid and Electrolytes Burton D. Rose, MD |
| 12:15 – 1:30 | Lunch Break |
| 12:30 – 1:30 | Meet the Professor Michael R. Rudnick, MD, Eduardo Slatopolsky, MD, FACP |
| 1:30 – 2:30 | Hyperophosphatemia: The Silent Killer of CKD Patients Eduardo Slatopolsky, MD, FACP |
| 2:30 – 3:00 | Refreshment Break |
| 3:00 – 4:15 | New Concepts on the Pathogenesis and Treatment of Metabolic Bone Disease Eduardo Slatopolsky, MD, FACP |
| 4:15 – 5:15 | Clinical Questions Robert S. Brown, MD |
| TUESDAY, MARCH 22 | |
| 7:00 – 7:30 | Continental Breakfast |
| 7:30 – 8:15 | Maintenance of Immunosuppression Martha Pavlakis, MD |
| 8:15 – 9:15 | HIV and Renal Disease Melanie P. Hoenig, MD |
| 9:15 – 9:45 | Refreshment Break |
| 9:45 – 10:45 | Management of the Failing Transplant Martha Pavlakis, MD |
| 10:45 – 12:00 | Topics in Interventional Nephrology: Catheters, Fistulas and Grafts Thomas M. Vesely, MD |
| 12:00 – 1:15 | Lunch Break |
| 12:15 – 1:15 | Meet the Professor Martha Pavlakis, MD, Thomas M. Vesely, MD, Gerald B. Appel, MD |
| 1:15 – 2:15 | Adequacy of PD John M. Burkart, MD |
| 2:15 – 3:15 | Modern Therapies in Lupus Nephritis Gerald B. Appel, MD |
| 3:15 – 3:45 | Refreshment Break |
| 3:45 – 4:45 | Common Problems in PD John M. Burkart, MD |
| 4:45 – 5:15 | Thrombotic Microangiopathies Gerald B. Appel, MD |
| WEDNESDAY, MARCH 23 | |
| 7:30 – 8:00 | Continental Breakfast |
| 8:00 – 9:00 | Challenging Glomerular Biopsy Cases Gerald B. Appel, MD |
| 9:00 – 10:00 | Small Vessel Vasculitis Ronald J. Falk, MD |
| 10:00 – 10:15 | Refreshment Break |
| 10:15 – 11:15 | Renal Aspects of Dysproteinemias Gerald B. Appel, MD |
| 11:15 – 12:00 | Efficacy of Immunosuppressive Drugs in Idiopathic Nephrotic Syndrome Ronald J. Falk, MD |
| 12:00 – 1:00 | IgA Nephropathy and H-S Purpura Ronald J. Falk, MD |
| THURSDAY, MARCH 24 | |
| 7:00 – 7:30 | Continental Breakfast |
| 7:30 – 8:30 | Management of Hypertension in Nephropathy and Diabetes George L. Bakris, MD, FASN |
| 8:30 – 9:30 | Management of Nondiabetic Chronic Renal Disease George L. Bakris, MD, FASN |
| 9:30 – 10:00 | Refreshment Break |
| 10:00 – 10:45 | Short Daily/Nocturnal Hemodialysis Andreas Pierratos, MD |
| 10:45 – 11:45 | Transplant 101: What You Need to Know Daniel C. Brennan, MD, FACP |
| 11:45m – 1:00 Lunch Break | |
| 12:00 – 1:00 | Meet the Professor Daniel C. Brennan, MD, FACP, Andreas Pierratos, MD |
| 1:00 – 2:00 | Renal Transplant in High Risk Kidney Recipients Daniel C. Brennan, MD, FACP |
| 2:00 – 3:00 | Pathology and Mechanisms of Glomerular Diseases Helmut G. Rennke, MD |
| 3:00 – 3:30 | Refreshment Break |
| 3:30 – 4:30 | Viral Infections in Renal Transplant Daniel C. Brennan, MD, FACP |
| 4:30 – 5:45 | Workshop: Glomerular Disease – Part I Burton D. Rose, MD, Helmut G. Rennke, MD |
| FRIDAY, MARCH 25 | |
| 7:00 – 7:30 | Continental Breakfast |
| 7:30 – 8:30 | Management of Anemia in ESRD Steve J. Schwab, MD |
| 8:30 – 9:30 | Cardiac Disease in ESRD William L. Henrich, MD, MACP |
| 9:30 – 9:45 | Refreshment Break |
| 9:45 – 10:30 | Hemodialysis Delivery: The Barriers to Adequate Dialysis Steve J. Schwab, MD |
| 10:30 – 12:00 | Workshop: Problems in Dialysis Steve J. Schwab, MD, William L. Henrich, MD, MACP |
| 12:00 – 1:15 | Lunch Break |
| 12:15 – 1:15 | Meet the Professor Steve J. Schwab, MD, Gary C. Curhan, MD, ScD |
| 1:15 – 2:15 | Renal Disease and Pregnancy Ravi I. Thadhani, MD |
| 2:15 – 3:15 | Renal Stones Gary C. Curhan, MD, ScD |
| 3:15 – 4:00 | Workshop: Renal Stones Gary C. Curhan, MD, ScD |
| 4:00 – 5:00 | Workshop: Glomerular Disease – Part II Burton D. Rose, MD, Helmut G. Rennke, MD |
*Note: Program changes/substitutions may be made without notice.
ATTENDANCE LIMITED
ACCREDITATION
|
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Harvard Medical School designates this educational activity for a maximum of 49 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Medical Association has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Last update 9.20.10 |
REGISTRATION INFORMATION
Tuition fee: $1,500 (USD)
Reduced fee for Residents* and Fellows in Training*: $1,000 (USD)
* A letter of verification from Department Chairman must accompany registration form/payment for a reduced fee for Residents/ Fellows in Training.
All foreign payments must be made by a draft on a United States
Bank or by Visa or MasterCard. Upon receipt of your registration form an email confirmation from the HMS-DCE office will be sent to you. Therefore, be sure to include an email address that you check daily/frequently. Your email address is used for critical information about the course including: registration confirmation, course evaluation and certificate. Tuition Refund Policy: A handling fee of $60 is deducted for cancellation. Refund requests must be received by mail or fax one week prior to the course. No refunds will be made thereafter. |
FACULTY
| Course Directors | |
|---|---|
| BURTON D. ROSE, MD Clinical Professor of Medicine, Harvard Medical School, Founding Editor, UpToDate, Inc. |
MARK L. ZEIDEL, MD Herrman L. Blumgart Professor of Medicine, Harvard Medical School, Physician-in-Chief and Chairman, Department of Medicine, Beth Israel Deaconess Medical Center |
| Faculty | |
| GERALD B. APPEL, MD Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, Director, Clinical Nephrology, Columbia University Medical Center |
GEORGE L. BAKRIS, MD, FASN Professor of Medicine, The University of Chicago Medical Center, Director, Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, The University of Chicago Medical Center |
| D. CRAIG BRATER, MD Dean and Walter J. Daly Professor, Indiana University School of Medicine |
DANIEL C. BRENNAN, MD, FACP Professor of Medicine, Washington University School of Medicine, Director, Transplant Nephrology, Barnes Jewish Hospital |
| ROBERT S. BROWN, MD Associate Professor of Medicine, Harvard Medical School, Clinical Chief, Renal Unit, Beth Israel Deaconess Medical Joslin Diabetes Center |
JOHN M. BURKART, MD Professor of Internal Medicine and Nephrology, Wake Forest University School of Medicine, Corporate Medical Director, Outpatient Dialysis, Wake Forest University Dialysis Facilities |
| DAVID A. CALHOUN, MD Professor of Medicine, Vascular Biology and Hypertension Program, Sleep/Wake Disorders Center, University of Alabama at Birmingham |
GARY C. CURHAN, MD, SCD Associate Professor of Medicine, Harvard Medical School, Associate Professor of Epidemiology, Harvard School of Public Health, Physician, Brigham and Women's Hospital |
| RONALD J. FALK, MD DJ Thurston Professor of Medicine, Director, UNC Kidney Center, The University of North Carolina at Chapel Hill, Chief, Division of Nephrology and Hypertension, University of North Carolina Hospitals |
WILLIAM L. HENRICH, MD, MACP President and Professor of Medicine, The University of Texas Health Science Center at San Antonio |
| MELANIE P. HOENIG, MD Assistant Professor of Medicine, Harvard Medical School, Staff Physician, Beth Israel Deaconess Medical Center, Joslin Clinic |
PAUL M. PALEVSKY, MD Professor of Medicine, University of Pittsburgh, Chief, Renal Section, VA Pittsburgh Healthcare System |
| MARTHA PAVLAKIS, MD Associate Professor of Medicine, Harvard Medical School, Medical Director, Kidney and Pancreas Transplantation, Beth Israel Deaconess Medical Center |
ANDREAS PIERRATOS, MD, FRCPC Associate Professor of Medicine, University of Toronto, Nephrologist, Humber River Regional Hospital |
| MARC A. POHL, MD Ray W. Gifford, Jr., MD Endowed Chair in Hypertension, Head, Section of Clinical Hypertension, The Cleveland Clinic |
HELMUT G. RENNKE, MD Professor of Pathology, Harvard Medical School, Director, Renal Pathology, Brigham and Women's Hospital |
| MICHAEL R. RUDNICK, MD Associate Professor of Medicine, University of Pennsylvania, School of Medicine, Chief, Renal Division, Penn Presbyterian Medical Center |
STEVE J. SCHWAB, MD Chancellor and Executive Dean, The University of Tennessee Health Science Center |
| EDUARDO SLATOPOLSKY, MD, FACP Joseph Friedman Professor of Renal Diseases in Medicine, Washington University School of Medicine, Physician, Barnes-Jewish Hospital |
THEODORE I. STEINMAN, MD Clinical Professor of Medicine, Harvard Medical School, Senior Physician, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital |
| RAVI I. THADHANI, MD, MPH Associate Professor of Medicine, Harvard Medical School, Director, Clinical Research Nephrology, Massachusetts General Hospital, Co-Director, Massachusetts Institute of Technology Clinical Research Center |
THOMAS M. VESELY, MD Interventional Radiologist, St. Louis, MO |
| WILLIAM F. YOUNG, JR., MD, MSC Professor of Medicine, Mayo Medical School, Consultant, Division of Endocrinology and Metabolism, Mayo Clinic |
|
|
Course # 312938
|
Copyright 2010, Harvard Medical School, Department of Continuing Education